The World Health Summit brings together leading researchers, physicians, government officials, and representatives from industry and civil society worldwide. Speakers at the World Health Summit 2019 include:
Verónica Michelle Bachelet Jeria is a Chilean politician who served as President of Chile from 2006 to 2010 and again from 2014 to 2018, the first woman to occupy the position. After leaving the presidency in 2010 and while not immediately reelectable, she was appointed the first executive director of the newly created United Nations Entity for Gender Equality and the Empowerment of Women (UN Women). In December 2013, Bachelet was reelected with over 62% of the vote, bettering the 54% she obtained in 2006. She was the first President of Chile to be reelected since 1932. In August 2018, the United Nations nominated her to become the next High Commissioner for Human Rights, replacing Zeid Raad Al Hussein.
Dr. Manica Balasegaram is Executive Director of the Global Antibiotic Research & Development Partnership (GARDP). He started his career in internal and emergency medicine at the University of Nottingham and has worked as a doctor and researcher in several countries in Sub- Saharan Africa and Southern Asia. He also gained significant experience working in humanitarian emergencies and responses, largely with Médecins sans Frontières (MSF). At the end of 2007 he joined the Drugs for Neglected Diseases before returning to MSF as Executive Director of their Access Campaign. He was appointed director of GARDP in June 2016. Manica’s experience spans clinical and public health practice in infectious diseases, international work on health policy & access to medicines. He also has substantial experience in clinical trials and drug development.
Prof. Till Bärnighausen is Director of the Heidelberg Institute of Global Health and an Alexander von Humboldt University Professor. He is a population health researcher who focuses on three areas of research: establishing the causal impacts of large-scale global health interventions – such as HIV treatment, HIV prevention, and childhood vaccination – on health, economic and social outcomes; identifying and testing innovations to improve the delivery of global health interventions through public-sector health systems; and developing new methods for applied population-based health research. He is also Adjunct Professor of Global Health at the Harvard T.H. Chan School of Public Health in the US and a Senior Faculty at the Wellcome Trust’s Africa Health Research Institute (ARHI) in South Africa.
Dr. Peter Beyer, a trained lawyer, is a senior WHO advisor responsible for all issues related to intellectual property and public health. He provides legal and technical advice and training to WHO headquarters and Member States. Previously, he was a Legal Advisor to the Swiss Federal Institute of Intellectual Property in Bern. He negotiated bilateral free trade agreements for the European Free Trade Association (EFTA), including with Algeria, the Golf Cooperation Council and South Korea and headed negotiations at WHO and WIPO. Furthermore, he was responsible for the bilateral dialog between Switzerland and China as well as all matters related to intellectual property rights and public health, development and human rights.
Dr. Mark Britnell has dedicated his entire professional life to healthcare and has led organisations at local, regional, national and global levels – provider and payer, public and private. Over the past 9 years, he has worked in 77 countries on ca. 300 occasions. He was previously Chief Executive of University Hospitals Birmingham and went on to run the NHS region from Oxford to the Isle of Wight before joining the NHS Management Board as a Director-General at the Department of Health. Between 2014 and 2018, he sat on the Global Agenda Council on the Future of the Health Sector for the World Economic Forum. Mark is the author of In Search of the Perfect Health System, which has sold in over 109 countries. His new book is Human: Solving the Global Workforce Crisis. A former board member of Prostate Cancer UK, Mark survived prostate cancer at the age of 42 and has donated all royalties from the sale of this book to Prostate Cancer UK.
Reinhard Busse is Professor of Healthcare Management at Technische Universität Berlin. He is also Co-Director of the European Observatory on Health Systems and Policies and a faculty member at Charité - Universitätsmedizin Berlin. His research focuses on health systems, particularly comparatively in Europe, looking at the conflicting priorities of the market and regulation as well as at performance assessment. His research also examines compensation mechanisms, integrated care, and the role of caregivers, as well as health economics and health technology assessment (HTA).
Dr Margaret Chan was the Director-General of World Health Organisation (WHO) from 2007 to 2017. Dr Chan joined WHO as Director of the Department for Protection of the Human Environment in 2003. She was elected Director-General in 2006 and was appointed for a second five-year term in 2012.
Prior to joining IFPMA, Thomas B. Cueni was Secretary General of Interpharma, the association of pharmaceutical research companies in Switzerland. For many years, he has been involved in the work of the European Federation of Pharmaceutical Industries and Associations, EFPIA, where he most recently served as Vice-Chair of the European Markets Committee and association representative on the Board. He also represented Interpharma, prior to which he had a career as a journalist.
Dr. Roopa Dhatt is a physician by training and an advocate by principle, striving for greater health and well-being for all people through working in global health. She is the Executive Director and co-founder of Women in Global Health, a movement that strives to bring greater gender equality to global health leadership. She serves on the Research in Gender and Ethics (RinGS) Advisory Board; Strategic Advisory Committee for the Global Health Workforce Network (GHWN); the Women Leaders in Global Health Conference Steering Committee; the Global Health 50-50 Advisory Council, Global Health Council Advisory Council, and the GlobeMed Advisory Board. She is an Internist, providing primary care in Washington D.C. at Kaiser Permanente. Areas of interest include: gender equality, primary health care, human security, global governance, global health diplomacy, and inter-sectorial collaborations.
Dr. Carissa F. Etienne has served as Director of the Pan American Health Organization since 2013. She was previously Assistant Director-General for Health Systems and Services at the World Health Organization in Geneva, Switzerland. During her tenures at WHO and PAHO, Dr. Etienne led the efforts to renew primary health care and to strengthen health systems based on primary health care, promoting integration and improved functioning of health systems. She has also spearheaded policy directions for reducing health inequalities and advancing health for all through universal coverage, people-centered care, the integration of health into broader public policies, and inclusive and participatory health leadership.
Dr Abdul Ghaffar has worked for over 30 years in low- and middle-income countries managing research for health; planning, designing and evaluating national health systems; and teaching health policy and management. Before joining the Alliance in 2010, Dr Ghaffar served as Regional Advisor for Research in the Eastern Mediterranean Office of the World Health Organization. Earlier, he worked as a Health Policy and Systems Specialist at the Global Forum for Health Research. Dr Ghaffar began his career in Pakistan as a public health physician, eventually transitioning into various senior leadership positions such as Assistant Director-General of Policy and Planning; Deputy Director-General of International Health; and Director of the Health Services Academy, a national school of public health.
Tedros Adhanom Ghebreyesus is an Ethiopian politician, academic, and public-health authority from Tigray who since 2017 has been Director-General of the World Health Organization. He served in the Government of Ethiopia as Minister of Health from 2005 to 2012 and as Minister of Foreign Affairs from 2012 to 2016. Tedros joined the Ministry of Health in 1986, after graduating from the University of Asmara. An internationally recognized malaria researcher, as Minister of Health, Tedros received praise for a number of innovative and system-wide health reforms that substantially improved access to health services and key outcomes. Amongst them were hiring and training roughly 40,000 female health extension workers, cutting infant mortality from 123 deaths per 1,000 live births in 2006 to 88 in 2011, and increasing the hiring of health cadres including medical doctors and midwives. In July 2009, he was elected Board Chair of The Global Fund to Fight AIDS, Tuberculosis and Malaria for a two-year term.
Ms Stefania Giannini was appointed UNESCO's Assistant Director-General for Education in May 2018, becoming the top United Nations official in the field of education. In this position, she provides strategic vision and leadership for UNESCO’s Education Sector in coordinating and monitoring the implementation of the Education 2030 Agenda, encapsulated in Sustainable Development Goal 4. She has devoted her career to promoting education as a fundamental human right, through the importance of language, lifelong learning, culture, freedom of expression and identity, in an effort to ensure more inclusive and equal societies.
Denis Gilhooly has over three decades of experience working in the field of global health and information and communication technology for development (ICT4D) in both the private sector and UN system. He is currently CEO, Global Digital He@lth 2030 Innovation Task Force & Co-Chair, Global Digital Health Initiative 2030 – multi-sector and inter-disciplinary partnerships dedicated to data-driven invention, innovation and investment for catalytic collaboration on UHC 2030 and the SDGs.
Dr. Gitahi is the Group CEO/Director-General Amref Health Africa and also Co-Chair of the UHC2030 WHO and World Bank initiative for achievement of UHC by 2030. Until his appointment at Amref Health Africa, Dr Gitahi was the Vice President and Regional Director Smile Train, a Global cleft charity. As a medical doctor, he worked both in the public and private sector. He has extensive experience working in the private sector having worked in senior executive roles at GlaxoSmithKIine and Nation Media Group.
He is also member of the Private Sector Advisory Board of Africa CDC and of the World Health Organization’s Community Health Worker Hub. He is member of the Board of Directors of The Standard Group and holds board member positions across Amref Health Africa offices in Africa.
Sir Andrew Haines was Director of the London School of Hygiene and Tropical Medicine (LSHTM) from 2001 to 2010. He continues his work there as Professor of Environmental Change and Public Health and sits on many national and international committees, including the Medical Research Council and the WHO Advisory Committee on Health Research. His research interests are in health systems and services research, as well as the implications of climate change on population health. He was knighted in 2005 for services to medicine.
Dr. Adnan Hyder is Senior Associate Dean for Research and Professor of Global Health at the Milken Institute School of Public Health of George Washington University. Previously, Dr. Hyder served as the Associate Chair of the Department of International Health and Director of the Health Systems Program at the Johns Hopkins Bloomberg School of Public Health. For over 20 years, Dr. Hyder has worked to improve global health in low- and middle- income countries across Africa, Asia, Latin America, and the Middle East; and pioneered empirical work around health systems, ethics, and injury prevention in the developing world.
As Executive Director, Dr. Jayasree K. Iyer leads the strategic direction and stakeholder engagement of the Access to Medicine Foundation. She directs the research programs for the Antimicrobial Resistance Benchmark, the Access to Medicine Index, the Access to Vaccines Index, and specific studies into priority health topics. Jayasree often speaks publicly on access-to-medicine matters on platforms hosted by international, governmental and non-governmental organizations, including the UN and WHO. In this capacity, she also engages with key pharmaceutical industry investors to support their engagement activities with pharma companies. She has written many technical and research reports, book chapters and reviews, along with strategy papers for medicines for developing countries and solutions for neglected tropical diseases. Before joining the Foundation, Jayasree managed a portfolio of more than 25 public private partnerships between the Dutch government and the pharmaceutical industry, totalling a research budget of €150 million. These partnerships addressed cancer, immunology and neglected diseases. She has worked for various non-government organisations, academic institutions and was part of the founding team of a diagnostic service company in the US.
After holding several positions including Staff Scientist at the Max Planck Institute for Immunobiology in Freiburg and Chair of the Department of Immunology at the University of Ulm, he became the Founding Director of the Max Planck Institute for Infection Biology in Berlin. The Microbiology and Immunology expert is a member of the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW) and the German National Academy of Sciences Leopoldina.
Ilona Kickbusch is the Director of the Global Health Program at the Graduate Institute of International and Development Studies, Geneva. She is a leading contributor to academic and political debates on governance for health at the national and the global level. She conducts global health diplomacy seminars in many countries and regions. She advises the WHO at global and regional level. In Switzerland she serves on the executive board of the Careum Foundation and as an advisor for Health 2020. She works with organizations, government agencies and the private sector on policies and strategies to promote health at the national, European and international level. She has published widely and is a member of a number of advisory boards in both the academic and the health policy arena.
Dr. Bronwyn King is a specialist radiation oncologist and founder and CEO of Tobacco Free Portfolios. She is also a Tobacco Control Ambassador for Cancer Council Australia and Diplomat of the Global Charter for World Federation of Public Health Federations. Dr. King has delivered two TEDx talks in the past year, calling for change in the global finance sector. A former elite swimmer, she was previously Team Doctor for the Australian Swimming Team.
Prof. Heyo Kroemer has been selected as the next CEO of Charité – Universitätsmedizin Berlin, a position he will assume in September, 2019. He is currently Chairman of the Managing Board of the Göttingen University Medical Center and Dean of the Faculty of Medicine at Georg-August-Universität Göttingen. Prof. Kroemer’s medical background is in pharmacology, with a research focus on drug metabolism and transport.
David Loew is currently Executive Vice-President of Sanofi Pasteur, the vaccines Global Business Unit of Sanofi, and a Member of the Executive Committee of Sanofi. Sanofi Pasteur manufactures and markets a diverse portfolio of vaccines, including influenza, meningitis, travel and endemic diseases. Sanofi Pasteur is a world leader in influenza and pediatric vaccines, and the first worldwide supplier of polio injectable vaccine. The vaccines help protect as many as half a billion lives each year against life-threatening diseases. Loew joined Sanofi in 2013 as Senior Vice-President of Commercial Operations, Europe, responsible for the pharmaceutical business across 38 countries. Before working for Sanofi, he spent 20 years with Roche, latterly as Region Head, Eastern Europe, Middle East and Africa and Global Chief Marketing Officer for the pharmaceutical division. Loew is a member of the Vaccine CEO Steering Committee, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), and a former Member of the Board at GAVI
Dr. Makanga is the Chief Executive Officer of the EDCTP Association Secretariat. He is a clinician-scientist born and raised in Uganda with 25 years of professional experience working on health and poverty-related diseases in sub-Saharan Africa. This includes 21 years of work experience on medical product development and clinical regulatory activities. He holds a Medical Degree from Makerere University, Uganda, and has been in various clinical and research positions before and after undertaking a Master’s Degree at the University of Liverpool, and then a PhD at the Liverpool School of Tropical Medicine, United Kingdom. He is also a Fellow of the Royal College of Physicians of Edinburgh, Scotland.
Volker ter Meulen qualified as MD in 1960 and received a training in virology in the USA. A specialist in pediatrics and in clinical virology, he became a full professor in 1975 and Chairman of the Institute of Virology and Immunobiology at Wuerzburg University. He retired in 2002, having twice been elected Dean of the Faculty of Medicine. During his research career, ter Meulen worked on molecular and pathogenic aspects of viral infections in man and animals, in particular on infections of the central nervous system. Ter Meulen has also advised German research organisations and ministries on research topics and served internationally on committees of numerous organisations and scientific societies. From 2003-2010, ter Meulen was President of the German Academy of Sciences Leopoldina. From 2007-2010, he was President of the European Academies Science Advisory Council (EASAC). Since 2017, ter Meulen has been President of the IAP.